Eudaimonia Asset Management »

Vaxcyte shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $881k 17k 50.98
2023-06-30 $3.0M 61k 49.94
2023-03-31 $1.9M 50k 37.48
2022-12-31 $3.1M 65k 47.95

More positions owned by Eudaimonia Asset Management

Powell Industries Common Stock (POWL)
Cymabay Therapeutics Common Stock
Aehr Test Systems Common Stock (AEHR)
MiMedx Group Common Stock (MDXG)
Hudson Technologies Common Stock (HDSN)
RxSight Common Stock (RXST)
Applied Optoelectronics Common Stock (AAOI)
Vivo Capital Common Stock (SLNO)
Gambling.com Group Common Stock (GAMB)
Limbach Holdings Common Stock (LMB)
Roivant Sciences Common Stock (IMVT)
Arlo Technologies Common Stock (ARLO)
PetIQ Common Stock (PETQ)
Newpark Resources Common Stock (NR)
Avita Medical Common Stock (RCEL)

View all positions for Eudaimonia Asset Management

Top funds holding Vaxcyte

Vanguard Group
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Associates
Alliancebernstein
Fred Alger Management
Jennison Associates
Westfield Capital Management Company
Braidwell
Frazier Life Sciences Management
OrbiMed Advisors
Commodore Capital
Perceptive Advisors
Franklin Resources

View all funds holding Vaxcyte